10-Q/APeriod: Q3 FY1994

JOHNSON & JOHNSON Quarterly Report (Amendment) for Q3 Ended Oct 2, 1994

Filed December 22, 1994For Securities:JNJ

Summary

This filing is an amendment to Johnson & Johnson's (JNJ) 10-Q report for the period ending October 1, 1994. As an amendment, it suggests that previously filed information may have been updated or corrected. Investors should note that this filing does not provide the financial statements or detailed operational discussions typically found in an original 10-Q. Therefore, its primary value lies in identifying potential revisions to earlier disclosures, which could impact the understanding of the company's financial performance and strategic position during that quarter. Given the limited content within the provided text, a deeper analysis of the specific amendments is not possible. Investors relying on this filing should seek access to the full amended 10-Q document to understand the nature and impact of any changes. Key areas to scrutinize would include revenue figures, profit margins, balance sheet items, and any commentary on business segments or future outlook that may have been altered.

Key Highlights

  • 1The filing is an amendment (10-Q/A) to a previously submitted quarterly report.
  • 2The report covers the period ending October 1, 1994.
  • 3The filing was made on December 21, 1994.
  • 4This document serves as a supplementary filing to an original 10-Q.
  • 5The provided text is a directory listing, not the full financial report.
  • 6Investors should consult the complete amended filing for specific details and changes.

Frequently Asked Questions

An amendment (10-Q/A) indicates that Johnson & Johnson is correcting or supplementing information previously filed in its original 10-Q report for the period ending October 1, 1994. Investors should review the amendment to understand what specific information has been revised and the potential impact on their assessment of the company's performance.

The provided text is a directory listing from the SEC EDGAR database and does not contain the full financial statements or management discussion and analysis. To access the complete financial data and details of the amendments, you would need to retrieve the full amended 10-Q filing document itself from the SEC EDGAR system.

This date signifies the end of the third fiscal quarter for Johnson & Johnson in 1994. The 10-Q report provides a snapshot of the company's financial condition and performance for this three-month period and the year-to-date results.

No, this is an amended filing. The primary filing would have been the original 10-Q report submitted earlier. This 10-Q/A is a follow-up to address any necessary corrections or additions to the initial report.